Dechra Pharmaceuticals PLC (LSE:DPH) Annual Report 2022



The latest annual report of Dechra Pharmaceuticals PLC (DPH) was published on 30 Jun 2022. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - DPH Annual Results

Amounts in GBP

Total Revenue
681.8M
Gross Profit
384.8M
EBIT
95.8M
Net Tangible Assets
-58.4M
Net Income
58.2M
Capital Expenditures
-20.3M

DPH Income Statement 2022 Annual Report

As per the latest Income Statement of DPH, the Net revenue increased by £73.80M (12%) compared to the previous period. The operating income in 2022 increased by £8.80M (10%). The net income as per the annual report was 58.2M which increased by £2.70M (5%) compared to previous year.

Income Statement Report (2022/2021)

20222021
Total Revenue681.8M608M
Gross Profit384.8M345.9M
Operating Income95.8M87M
Income Before Tax77.6M74M
Net Income58.2M55.5M

Balance Sheet - DPH 2022 Annual Report

Read further: DPH Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Dechra Pharmaceuticals PLC showed the company increased the cash on balance sheet by £2.50M (2%). The Net tangible assets of DPH on the balance sheet were at -58.4M which is £18.90M (24%) more than previous annual report. The total stockholder equity also increased by £33.90M (5%) compared to previous reporting period.

Balance Sheet Statement Report (2022/2021)

20222021
Cash120.9M118.4M
Total Assets1.29B 1.21B
Long Term Debt313.7M302.7M
Total Liabilities626.5M 581.2M
Total Shareholder Equity666.8M632.9M
Net Tangible Assets-58.4M-77.3M

Cash Flow Statement - DPH 2022 Annual Report

The 2022 annual cash flow statement of Dechra Pharmaceuticals PLC showed that the net income increased by £2.70M (5%) compared to previous reporting period. Also the capital expenditure of DPH decreased by £-1.40M (-7%).

As of 2022, the total cash from investing activities was -78.3M and total cash from financing activities was -46.1M.

Cash Flow Statement Report (2022/2021)

20222021
Net Income58.2M55.5M
Capital Expenditures-20.3M-18.9M
Dividends Paid-44.8M-37.9M
Total Cash From From Investing Activities-78.3M-136.1M
Total Cash From From Financing Activities-46.1M-55.1M

Dechra Pharmaceuticals PLC Annual Report History

Income Statement

Income Statement history of Dechra Pharmaceuticals PLC (LSE:DPH)

30 Jun 202230 Jun 202130 Jun 202030 Jun 2019
Total Revenue681.8M608M515.1M481.8M
Cost Of Revenue297M262.1M223.5M203.6M
Gross Profit384.8M345.9M291.6M278.2M
Research Development36.1M36.8M34.1M31.9M
Selling General Administrative252.9M222.1M198.8M195.7M
Non Recurring----
Other Operating Expenses----
Total Operating Expenses586M521M456.4M431.2M
Operating Income95.8M87M58.7M50.6M
Total Other Income Expense Net-18.2M-13M-17.8M-22.8M
Ebit95.8M87M58.7M50.6M
Interest Expense-8.8M-8.8M-11.5M-10.5M
Income Before Tax77.6M74M40.9M27.8M
Income Tax Expense19.4M18.5M7M-3.1M
Minority Interest----
Net Income From Continuing Ops58.2M55.5M33.9M30.9M
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income58.2M55.5M33.9M30.9M
Net Income Applicable To Common Shares58.2M55.5M33.9M30.9M

Balance Sheet Statement

Balance Sheet Statement history of Dechra Pharmaceuticals PLC (LSE:DPH)

30 Jun 202230 Jun 202130 Jun 202030 Jun 2019
Cash120.9M118.4M227.4M80.3M
Net Receivables142.1M119.2M97.3M103.8M
Inventory175.7M149.5M120.8M103.5M
Total Current Assets444.4M392.2M448.9M291.5M
Long Term Investments15.8M17.1M17.4M10.1M
Property Plant Equipment100.3M87M76.4M58.4M
Good Will245.4M236.1M253.8M245.7M
Intangible Assets479.8M474.1M432.3M429.4M
Other Assets7.6M7.6M8.8M6.4M
Deferred Long Term Asset Charges2.3M2M2.7M900k
Total Assets1.29B1.21B1.24B1.04B
Accounts Payable46M35.2M34.6M31.9M
Other Current Liab21.7M43.1M37.6M23.3M
Long Term Debt313.7M302.7M338.6M306.9M
Other Liab142M109.9M112.4M107.4M
Deferred Long Term Liab5.3M5.6M6.1M5.5M
Total Current Liabilities158.7M155.8M137.3M118.1M
Total Liab626.5M581.2M600.1M532.4M
Common Stock1.1M1.1M1.1M1M
Retained Earnings164M147.7M126.4M124.2M
Treasury Stock87.8M72.5M100.7M106M
Capital Surplus413.9M411.6M409.3M277.9M
Other Stockholder Equity87.8M72.5M100.7M106M
Total Stockholder Equity666.8M632.9M637.5M509.1M
Net Tangible Assets-58.4M-77.3M-48.6M-166M

Cash Flow Statement

Cash Flow Statement history of Dechra Pharmaceuticals PLC (LSE:DPH)

30 Jun 202230 Jun 202130 Jun 202030 Jun 2019
Net Income58.2M55.5M33.9M30.9M
Depreciation47.3M40M25.8M21M
Change To Netincome1.3M-20.9M-2.6M-16.2M
Change To Account Receivables-23.4M-19.7M6.9M-11.7M
Change To Liabilities14.9M20.3M100k6.3M
Change To Inventory-19.3M-36.6M-15.7M-14.1M
Total Cash From Operating Activities122.9M89.1M106.4M81.8M
Capital Expenditures-20.3M-18.9M-7.8M-12M
Other Cashflows From Investing Activities100k100k300k300k
Total Cashflows From Investing Activities-78.3M-136.1M-81.5M-61.9M
Dividends Paid-44.8M-37.9M-33.3M-28.4M
Net Borrowings-3.6M-19.5M22.4M7.3M
Total Cash From Financing Activities-46.1M-55.1M118.9M-20.1M
Effect Of Exchange Rate4M-6.9M3.3M800k
Change In Cash2.5M-109M147.1M600k
Issuance Of Stock2.3M2.3M131.5M1.2M